NASACORT ALLERGY 24HR SPRAY, METERED DOSE

Negara: Kanada

Bahasa: Inggris

Sumber: Health Canada

Bahan aktif:

TRIAMCINOLONE ACETONIDE

Tersedia dari:

SANOFI CONSUMER HEALTH INC

Kode ATC:

R01AD11

INN (Nama Internasional):

TRIAMCINOLONE

Dosis:

55MCG

Bentuk farmasi:

SPRAY, METERED DOSE

Komposisi:

TRIAMCINOLONE ACETONIDE 55MCG

Rute administrasi :

NASAL

Unit dalam paket:

60/120 ACT

Jenis Resep:

OTC

Area terapi:

CORTICOSTEROIDS

Ringkasan produk:

Active ingredient group (AIG) number: 0106310013; AHFS:

Status otorisasi:

APPROVED

Tanggal Otorisasi:

2015-01-14

Karakteristik produk

_NASACORT_
_®_
_ Allergy 24 HR _
_Page 1 of 30 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
NASACORT® Allergy 24HR
Triamcinolone Acetonide Nasal Spray, USP
Aqueous Nasal Spray 55mcg/ Metered Spray
Corticosteroid for Nasal Use
Sanofi Consumer Health Inc.
2905 Place Louis R.-Renaud
Laval, Quebec H7V 0A3
Date of Revision:
August 25, 2022
Submission Control Number: 261449
_NASACORT_
_®_
_ Allergy 24 HR _
_Page 2 of 30 _
RECENT MAJOR LABEL CHANGES
Section 7, Warnings and Precautions
04/2022
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED.
RECENT MAJOR LABEL CHANGES ...............................................................................
2
TABLE OF CONTENTS .....................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION ..................................................... 4
1
INDICATIONS .........................................................................................................
4
1.1
Pediatrics
...................................................................................................................
4
1.2
Geriatrics
...................................................................................................................
4
2
CONTRAINDICATIONS .........................................................................................
4
4
DOSAGE AND ADMINISTRATION .......................................................................
4
4.1
Dosing Considerations
..............................................................................................
4
4.2
Recommended Dose and Dosage Adjustment
.......................................................... 5
4.4. Administration
..........................................................................................................
5
4.5 Missed dose
..............................................................................................................
5
5
OVERDOSAGE